Professional Publisher (Small)
|Owner||F1000Research Ltd is a member of Taylor & Francis Group|
34-42 Cleveland Street
London W1T 4LB
|Copyright and Licensing||http://f1000research.com/about
|Copyright and Licensing Policy||F1000Research uses the most open of the standard Creative Commons licences (CCBY; http://creativecommons.org/licenses/by/4.0/)
as the default for submissions, which leaves copyright of the content with whomever was the copyright holder (usually the author or institution) and enables text mining.
|Complaint email||Contact details are on individual Platform websites, for example https://f1000research.com/contact - the Editorial contact email should be used.|
|Complaint policy||F1000Research is a member of COPE and any complaints would be handled according to COPE guidelines. Any complaints should be addressed to the editorial office in the first instance. Any complaints should be addressed to the editorial office in the first instance. Details of the current policies are on individual Platform websites, for example: http://f1000research.com/about/policies|
|Publication charge link||http://f1000research.com/for-authors/article-processing-charges|
|Publication charge policy||Fees are payable based on Article Type.
F1000Research Advisory Board members receive a 20% discount.
F1000Research reviewers: All reviewers receive a 20% discount on one article submitted within the ensuing 12 months.
Discounts cannot be combined to cover the fee for a single article. If authors on an article are eligible for various individual discounts, the largest discount is applied.
We fully support the HINARI/AGORA Access to Research in Health Programme. For articles presenting original research a full waiver is given to authors whose main funder is in the HINARI Group A countries, and a 50% discount to authors whose main funder is in the Group B countries. If no formal funding was received, the country of origin of most authors' institutions will be taken as the source country. If there is no majority country, the primary affiliation country of the corresponding author will determine waiver eligibility.
|OASPA Compliant OA Journals||1|
approx. number in 12 months
|c. 1300 in 2020|
|Initiatives||All articles in F1000Research are published as open access. F1000Research also publishes posters, slides, and documents.|
|Peer review policy||F1000Research operates a formal post-publication open peer review process. Referees’ reviews are published, attributed and permanently attached to the article. See http://f1000research.com/about
Articles that pass this formal peer review process are then indexed in PubMed, Scopus and other major bibliographic databases.